ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
TCR 치료 시장 규모는 최근 비약적으로 확대되고 있습니다. 2025년 2억 6,000만 달러에서 2026년에는 3억 5,000만 달러에 이르고, CAGR 35.5%의 성장이 전망되고 있습니다. 지금까지의 성장은 자가 TCR 치료의 조기 도입, 유전자 편집 기술의 발전, 암 면역치료 임상시험 증가, 혈액 악성종양 발생률 증가, 바이오기업과 병원 간 협력 등이 요인으로 꼽힙니다.
TCR 치료 시장 규모는 향후 몇 년간 급성장이 전망되고 있습니다. 2030년에는 11억 5,000만 달러에 이르고, CAGR은 34.8%를 나타낼 전망입니다. 예측 기간 동안 성장 요인으로는 기성품 동종 TCR 치료제의 확대, TCR 설계에 AI 통합, 신흥 시장 진출 확대, 신규 TCR 적응증에 대한 규제 승인, 병용 면역요법 접근법의 발전 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 개인 맞춤형 TCR 치료제 개발, 기성품 동종 TCR 치료제, 병용 면역요법 접근법, 병원 및 전문 클리닉 접근성 확대, 첨단 TCR 유전자 편집 기술 등이 있습니다.
암 발생률 증가는 향후 몇 년 동안 T세포 수용체(TCR) 치료제 시장의 성장을 견인할 것으로 예측됩니다. 암은 비정상적인 세포의 통제 불가능한 증식과 확산을 특징으로 하는 질병군으로 노화, 생활습관 위험, 유전적 소인, 환경적 노출 등의 요인에 의해 영향을 받습니다. 암 환자 증가는 전 세계적으로 질병 부담을 증가시키고 있으며, 보다 정밀하고 지속적인 임상 결과를 제공하는 첨단 치료 솔루션에 대한 절실한 요구가 발생하고 있습니다. TCR 치료는 T세포를 변형시켜 암세포를 특이적으로 식별하고 제거하도록 함으로써 이러한 증가하는 의료 수요에 대응하고, 복잡하고 치료 저항성이 있는 종양에 대한 고도의 표적화된 면역치료 접근법을 제공합니다. 예를 들어, 미국 비영리단체인 미국암협회(American Cancer Society)에 따르면, 신규 림프종 추정 환자 수는 2022년 8만 9,010명에서 2023년 8만 9,380명으로 증가할 것으로 예측됩니다. 그 결과, 암 발생률 증가는 TCR 치료 시장의 성장을 가속하고 있습니다.
TCR 치료 산업에서 사업을 전개하는 주요 기업들은 환자에게 필수적인 치료를 제공하고 시장에서의 경쟁 우위를 확보하기 위해 전략적 제휴 접근법을 추진하고 있습니다. 전략적 제휴는 상호 이익과 성공을 달성하기 위해 각 사가 서로의 강점과 자원을 활용하는 과정을 말합니다. 예를 들어, 2023년 12월, 미국 소재 생명공학 기업 ImmunoScape는 싱가포르 소재 제약사 EDDC(Experimental Drug Development Centre)와 협력하여 고형 종양에 대한 새로운 TCR 기반 이중 특이성 분자를 개발했습니다. 기반 이중 특이성 분자를 개발했습니다. 이번 제휴는 ImmunoScape의 시스템 면역학 및 계산생물학 분야의 전문성과 EDDC의 기술력을 결합하여 해당 분야의 연구를 촉진하고, 양사의 고유한 강점을 활용한 전략적 제휴 관계를 구축하여 보다 접근성이 높고 잠재적으로 효과적인 암 치료제 개발을 가속화하기 위한 것입니다. 가속화하는 것을 목표로 하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 TAM(Total Addressable Market) 규모
제9장 시장 세분화
제10장 지역별/국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 주요 기업 및 혁신 기업
제38장 세계 시장 경쟁 벤치마킹과 대시보드
제39장 주요 인수합병(M&A)
제40장 시장 잠재력이 높은 국가, 부문, 전략
제41장 부록
LSH
영문 목차
영문목차
T-cell receptor (TCR) therapy is a type of immunotherapy that involves altering a patient's T cells to enhance their ability to identify and attack cancer cells. It is mainly used for treating cancer and aims to utilize the body's immune system to target and eliminate cancer cells.
The main types of TCR therapy include infusions, injectables, and others. Infusions typically involve steeping or soaking a substance (such as herbs, tea leaves, or flavorings) in a liquid (usually hot water) to extract its properties or flavor. They are applied to treat various conditions, including leukemia, lymphoma, myeloma, and others, and are distributed through both online and offline channels. They are utilized by several end-users, including hospital pharmacies, retail pharmacies, and specialty clinics.
Tariffs have affected the TCR therapy market by increasing the cost of imported gene-editing reagents, cell culture media, and manufacturing equipment. This has particularly impacted segments such as autologous and allogeneic TCR infusions, with North America and Europe facing higher production costs due to reliance on imported materials. Some companies are benefiting by localizing manufacturing and sourcing reagents domestically, which can reduce costs and improve supply chain resilience. Overall, tariffs have created a mixed impact, slowing adoption in some regions while driving innovation and localized production strategies.
The tcr therapy market research report is one of a series of new reports from The Business Research Company that provides tcr therapy market statistics, including tcr therapy industry global market size, regional shares, competitors with a tcr therapy market share, detailed tcr therapy market segments, market trends and opportunities, and any further data you may need to thrive in the tcr therapy industry. This tcr therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The tcr therapy market size has grown exponentially in recent years. It will grow from $0.26 billion in 2025 to $0.35 billion in 2026 at a compound annual growth rate (CAGR) of 35.5%. The growth in the historic period can be attributed to early adoption of autologous tcr therapies, advancements in gene editing technologies, increasing clinical trials for cancer immunotherapy, rising incidence of hematologic malignancies, collaborations between biotech firms and hospitals.
The tcr therapy market size is expected to see exponential growth in the next few years. It will grow to $1.15 billion in 2030 at a compound annual growth rate (CAGR) of 34.8%. The growth in the forecast period can be attributed to growth in off-the-shelf allogeneic tcr therapies, integration of ai for tcr design, expansion in emerging markets, regulatory approvals for new tcr indications, advancements in combination immunotherapy approaches. Major trends in the forecast period include personalized tcr therapy development, off-the-shelf allogeneic tcr therapies, combination immunotherapy approaches, expansion of hospital and specialty clinic access, advanced tcr gene editing techniques.
The rising incidence of cancer is anticipated to drive the growth of the T-cell receptor (TCR) therapy market in the coming years. Cancer encompasses a group of diseases characterized by the uncontrolled proliferation and spread of abnormal cells, influenced by factors such as aging populations, lifestyle-related risks, genetic predispositions, and environmental exposures. The increasing number of cancer cases is expanding the global disease burden, creating a pressing need for advanced therapeutic solutions that deliver more precise and lasting clinical outcomes. TCR therapy addresses this growing medical demand by engineering T cells to specifically identify and eliminate cancer cells, offering a highly targeted immunotherapy approach for complex and treatment-resistant tumors. For example, according to the American Cancer Society, a US-based non-profit organization, the estimated new lymphoma cases rose from 89,010 in 2022 to 89,380 in 2023. Consequently, the rising incidence of cancer is fueling the growth of the TCR therapy market.
Major companies operating in the TCR therapy industry are pursuing a strategic partnership approach to deliver essential treatments to patients and secure a competitive advantage in the market. Strategic partnerships involve a process in which companies utilize each other's strengths and resources to achieve mutual benefits and success. For example, in December 2023, ImmunoScape, a US-based biotechnology company, collaborated with the Experimental Drug Development Centre (EDDC), a Singapore-based pharmaceutical company, to develop new TCR-based bispecific molecules for solid tumors. This collaboration aims to combine ImmunoScape's expertise in systems immunology and computational biology with EDDC's capabilities to advance research in this area and establish a strategic alliance that harnesses their unique strengths to accelerate the development of more accessible and potentially more effective cancer treatments.
In January 2023, AstraZeneca, a UK-based pharmaceutical and biotechnology company, acquired Neogene Therapeutics Inc. for $320 million. This acquisition enabled AstraZeneca to strengthen its position in the rapidly growing field of TCR-T therapy. AstraZeneca obtained access to advanced technology, valuable expertise, and a shared commitment to developing new cancer treatments, ultimately aiming to enhance the lives of patients with various types of cancer. Neogene Therapeutics Inc. is a US-based biotechnology company focused on developing next-generation, fully personalized engineered T-cell therapies for a wide range of cancers.
Major companies operating in the tcr therapy market are Immunocore Limited, Immatics N.V., Adaptimmune Therapeutics plc, Alaunos Therapeutics Inc., Zelluna Immunotherapy AS, Lion TCR Pte Ltd, TCRCure Biopharma Corp., China Immunotech Inc., Bluebird bio Inc., Poseida Therapeutics Inc., Fate Therapeutics Inc., Atara Biotherapeutics Inc., Precision Biosciences Inc., Cellectis S.A., Cellular Biomedicine Group Inc., Takara Bio Inc., Tessa Therapeutics, Pfizer Inc., Novartis AG, Bristol Myers Squibb Company
North America was the largest region in the TCR therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tcr therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the tcr therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The TCR therapy market consists of revenues earned by entities by providing services such as genetic engineering services, quality control and assurance, clinical trial support, and consulting services. The market value includes the value of related goods sold by the service provider or included within the service offering. The TCR therapy market also includes sales of TCR constructs, genetic modification tools, viral vectors, delivery systems, cell culture media and reagents, patient monitoring tools, and bioinformatics and data analysis tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
TCR Therapy Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses tcr therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for tcr therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The tcr therapy market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Product Type: Infusions; Injectables; Other Product Types
2) By Indication: Leukemia; Lymphoma; Myeloma; Other Indication
3) By Distribution Channel: Online; Offline
4) By End-User: Hospital Pharmacy; Specialty Clinics
Subsegments:
1) By Infusions: Autologous TCR Infusions; Allogeneic TCR Infusions
2) By Injectables: TCR-based Injectable Formulations; Injectable TCR Gene Therapies
3) By Other Product Types: TCR-Engineered Cell Therapies; TCR Combination Therapies with Other Immunotherapies; TCR-Based Biologics
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
4.1.4 Industry 4.0 & Intelligent Manufacturing
4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
4.2.1 Personalized Tcr Therapy Development
4.2.2 Off-The-Shelf Allogeneic Tcr Therapies
4.2.3 Combination Immunotherapy Approaches
4.2.4 Expansion Of Hospital And Specialty Clinic Access
4.2.5 Advanced Tcr Gene Editing Techniques
5. TCR Therapy Market Analysis Of End Use Industries
5.1 Hospital Pharmacy
5.2 Specialty Clinics
5.3 Research Institutes
5.4 Academic Medical Centers
5.5 Retail Pharmacy
6. TCR Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global TCR Therapy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global TCR Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global TCR Therapy Market Size, Comparisons And Growth Rate Analysis
7.3. Global TCR Therapy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global TCR Therapy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global TCR Therapy Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. TCR Therapy Market Segmentation
9.1. Global TCR Therapy Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Infusions, Injectables, Other Product Types
9.2. Global TCR Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Leukemia, Lymphoma, Myeloma, Other Indication
9.3. Global TCR Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Online, Offline
9.4. Global TCR Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospital Pharmacy, Specialty Clinics
9.5. Global TCR Therapy Market, Sub-Segmentation Of Infusions, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.7. Global TCR Therapy Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
TCR-Engineered Cell Therapies, TCR Combination Therapies with Other Immunotherapies, TCR-Based Biologics
10. TCR Therapy Market Regional And Country Analysis
10.1. Global TCR Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global TCR Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
11. Asia-Pacific TCR Therapy Market
11.1. Asia-Pacific TCR Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific TCR Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China TCR Therapy Market
12.1. China TCR Therapy Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China TCR Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India TCR Therapy Market
13.1. India TCR Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan TCR Therapy Market
14.1. Japan TCR Therapy Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan TCR Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia TCR Therapy Market
15.1. Australia TCR Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia TCR Therapy Market
16.1. Indonesia TCR Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea TCR Therapy Market
17.1. South Korea TCR Therapy Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea TCR Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan TCR Therapy Market
18.1. Taiwan TCR Therapy Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan TCR Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia TCR Therapy Market
19.1. South East Asia TCR Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia TCR Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe TCR Therapy Market
20.1. Western Europe TCR Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe TCR Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK TCR Therapy Market
21.1. UK TCR Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany TCR Therapy Market
22.1. Germany TCR Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France TCR Therapy Market
23.1. France TCR Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy TCR Therapy Market
24.1. Italy TCR Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain TCR Therapy Market
25.1. Spain TCR Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe TCR Therapy Market
26.1. Eastern Europe TCR Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe TCR Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia TCR Therapy Market
27.1. Russia TCR Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America TCR Therapy Market
28.1. North America TCR Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America TCR Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA TCR Therapy Market
29.1. USA TCR Therapy Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA TCR Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada TCR Therapy Market
30.1. Canada TCR Therapy Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada TCR Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America TCR Therapy Market
31.1. South America TCR Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America TCR Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil TCR Therapy Market
32.1. Brazil TCR Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East TCR Therapy Market
33.1. Middle East TCR Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East TCR Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa TCR Therapy Market
34.1. Africa TCR Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa TCR Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. TCR Therapy Market Regulatory and Investment Landscape
36. TCR Therapy Market Competitive Landscape And Company Profiles
36.1. TCR Therapy Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. TCR Therapy Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. TCR Therapy Market Company Profiles
36.3.1. Immunocore Limited Overview, Products and Services, Strategy and Financial Analysis
36.3.2. Immatics N.V. Overview, Products and Services, Strategy and Financial Analysis
36.3.3. Adaptimmune Therapeutics plc Overview, Products and Services, Strategy and Financial Analysis
36.3.4. Alaunos Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.5. Zelluna Immunotherapy AS Overview, Products and Services, Strategy and Financial Analysis
37. TCR Therapy Market Other Major And Innovative Companies
Lion TCR Pte Ltd, TCRCure Biopharma Corp., China Immunotech Inc., Bluebird bio Inc., Poseida Therapeutics Inc., Fate Therapeutics Inc., Atara Biotherapeutics Inc., Precision Biosciences Inc., Cellectis S.A., Cellular Biomedicine Group Inc., Takara Bio Inc., Tessa Therapeutics, Pfizer Inc., Novartis AG, Bristol Myers Squibb Company
38. Global TCR Therapy Market Competitive Benchmarking And Dashboard
39. Key Mergers And Acquisitions In The TCR Therapy Market
40. TCR Therapy Market High Potential Countries, Segments and Strategies
40.1 TCR Therapy Market In 2030 - Countries Offering Most New Opportunities
40.2 TCR Therapy Market In 2030 - Segments Offering Most New Opportunities
40.3 TCR Therapy Market In 2030 - Growth Strategies
